Loading...
Loading...
Novo Nordisk announced it will reduce the US list prices for its weight-loss and diabetes drugs Ozempic and Wegovy. The price cuts, which will take effect in 2027, could be as much as 50%. This move addresses growing pressure over the high cost of these popular medications.
by WorldBrief & Maksim Micheliov | AI-generated summary
A wrong detail, a missing source, or an event on the wrong conflict? Tell me. I read everything.
6 headlines from 6 publishers
